CONSORT MEDICAL PLC

CSRT
No quotes available
--GBX 0.00%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: April 2014 2015 2016 2017 2018 2019
Net sales1 100185277294311305
EBITDA1 23,623,239,951,454,754,3
Operating profit (EBIT)1 18,015,129,539,241,641,0
Operating Margin 18,0%8,17%10,7%13,3%13,4%13,4%
Pre-Tax Profit (EBT)1 16,15,5111,321,917,312,5
Net income1 13,04,9515,022,616,110,5
Net margin 13,0%2,68%5,42%7,69%5,18%3,44%
EPS2 0,380,120,300,460,330,21
Dividend per Share2 0,180,180,190,200,210,21
Last update 07/29/201507/28/201606/29/201707/30/201807/31/201907/31/2019
1 GBP in Million
2 GBP
Finances - Leverage
Fiscal Period: April 2014 2015 2016 2017 2018 2019
Net Debt1 -99,297,092,695,597,4
Net Cash position1 25,8-----
Leverage (Debt / EBITDA) -1,09x4,28x2,43x1,80x1,75x1,79x
Free Cash Flow1 -6,702,28-6,3914,313,813,0
ROE (Net Profit / Equities) 12,3%3,93%7,81%10,7%7,02%4,33%
Shareholders' equity1 106126192211229242
ROA (Net Profit / Asset) 7,86%3,08%4,03%5,40%5,57%5,47%
Assets1 165161372418289192
Book Value Per Share2 4,114,124,284,345,034,85
Cash Flow per Share2 0,900,930,330,450,440,28
Capex1 16,120,521,118,020,922,7
Capex / Sales 16,1%11,1%7,62%6,12%6,72%7,44%
Last update 07/29/201507/28/201606/29/201707/30/201807/31/201907/31/2019
1 GBP in Million
2 GBP
Balance Sheet Analysis
Price Earning Ratio
EPS & Dividend